{
    "id": "med_recon_chart_v1",
    "type": "chartExhibit",
    "exhibits": [
        {
            "id": "e1",
            "title": "Home Medication List",
            "content": "• Warfarin 5 mg PO daily\n• Atorvastatin 20 mg PO daily\n• Metformin 500 mg PO BID\n• Garlic supplement 500 mg daily"
        },
        {
            "id": "e2",
            "title": "Admission Orders",
            "content": "• Warfarin 5 mg PO daily\n• Enoxaparin 40 mg SC BID\n• Metformin 500 mg PO BID\n• Regular Insulin sliding scale"
        }
    ],
    "stem": "A client is admitted for a deep vein thrombosis (DVT). The nurse reviews the home medication list and the admission orders. Which finding in the chart requires immediate follow-up with the healthcare provider?",
    "options": [
        {
            "id": "c",
            "text": "The continued use of a garlic supplement with anticoagulants."
        },
        {
            "id": "b",
            "text": "The continuation of metformin while the client is receiving insulin."
        },
        {
            "id": "a",
            "text": "The addition of enoxaparin while the client is on warfarin."
        },
        {
            "id": "d",
            "text": "The omission of atorvastatin from the admission orders."
        }
    ],
    "correctOptionId": "c",
    "pedagogy": {
        "bloomLevel": "analyze",
        "cjmmStep": "analyzeCues",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 3,
        "topicTags": [
            "Medication Reconciliation",
            "Anticoagulants",
            "Herbal Supplements",
            "Drug Interactions",
            "Patient Safety"
        ]
    },
    "answerBreakdown": [
        {
            "key": "c",
            "content": "This is the correct answer because it identifies the most immediate life-threatening risk. Garlic contains compounds like allicin, which possess antiplatelet properties by irreversibly inhibiting thromboxane synthesis. This action, when combined with warfarin's inhibition of vitamin K-dependent clotting factors (II, VII, IX, X) and enoxaparin's potentiation of antithrombin to inactivate Factor Xa, creates a synergistic effect. The patient is receiving two prescribed anticoagulants plus an herbal supplement that impairs platelet aggregation, drastically increasing the risk for spontaneous and uncontrolled hemorrhage."
        },
        {
            "key": "b",
            "content": "This is incorrect. Concurrent use of metformin and insulin is a common and appropriate therapeutic strategy, especially in an acutely ill, hospitalized patient. The admission for DVT represents a physiological stressor that can cause stress-induced hyperglycemia. Metformin works by decreasing hepatic glucose production and increasing insulin sensitivity, but its action may be insufficient to control acute glycemic excursions. The sliding scale insulin provides rapid, titratable correction for high blood glucose levels, ensuring tighter glycemic control and preventing hyperglycemic complications."
        },
        {
            "key": "a",
            "content": "This is incorrect as it describes standard bridging therapy for acute DVT. Warfarin's mechanism of action—inhibiting the synthesis of new vitamin K-dependent clotting factors—results in a delayed therapeutic onset (3-5 days). It does not affect already circulating clotting factors. Enoxaparin, a low-molecular-weight heparin, provides immediate anticoagulation by potentiating antithrombin III. Therefore, enoxaparin is administered concurrently to provide immediate therapeutic coverage until the warfarin achieves a therapeutic International Normalized Ratio (INR), typically 2.0-3.0."
        },
        {
            "key": "d",
            "content": "This is incorrect because while it is a medication reconciliation error that requires clarification, it is not the most immediate threat. Atorvastatin is an HMG-CoA reductase inhibitor used for long-term management of hyperlipidemia to reduce future cardiovascular risk. The temporary omission of a few doses does not pose an acute risk to the client's safety or hemodynamic stability, unlike the severe bleeding risk posed by the drug-herb interaction."
        }
    ],
    "questionTrap": "The primary trap is failing to prioritize risks. Candidates may identify the concurrent use of two anticoagulants (warfarin and enoxaparin) as a dangerous error, not recognizing it as standard 'bridging' therapy. Another trap is focusing on the omitted atorvastatin as a critical error, without weighing its long-term purpose against the immediate, life-threatening hemorrhage risk posed by the garlic supplement interaction.",
    "mnemonics": "To remember common substances that increase bleeding risk when taken with anticoagulants, use the '5 G's and an A':\n• Garlic\n• Ginger\n• Ginkgo Biloba\n• Ginseng\n• Glucosamine\n• Aspirin (and NSAIDs)",
    "scoring": {
        "method": "dichotomous",
        "maxPoints": 1
    }
}